Dr. Anand has experience in providing intensive care for newborn infants including extracorporeal life support (ECLS). At Sidra Medicine, Dr Anand has contributed to the development and delivery of Neonatal ECLS and is now the clinical lead for Neonatal ECLS program. He has also established Congenital Diaphragmatic Hernia-Qatar (CDH-Q) for which he is the program lead. In addition, he has interest in patient safety and quality improvement and has done Scottish Patient Safety Program (SPSP) fellowship. He has developed and implemented projects to reduce central line infections, measuring and monitoring of adverse events, delivering evidence-based medicine to improve neonatal outcomes and safety, and promoting family integrated care. He is also a founding member of United Kingdom Health Foundation’s Q initiative.

Dr. Anand was awarded PhD from University of Liverpool, United Kingdom, for his research on first trimester fetal loss (vanishing twin) in a twin pregnancy and its consequences on surviving twin. His other research interests include perinatal epidemiology, genetics, neurodevelopmental follow up and neuroimaging.